cGxP.wire https://validator.w3.org/feed/docs/rss2.html Amgen and AstraZeneca Report Positive Phase 3 TEZSPIRE Results in EoE Aardvark Therapeutics Announces FDA Lifts ARD-101 Clinical Hold IceCure Begins ProSense Breast Cancer Cryoablation Study Prilenia and Ferrer Secure EU Authorization for PRECISE-HD Trial Cognition Therapeutics Aligns with FDA on Phase 3 DLB Trial Synergy Spine Reports Real-World Results for Synergy Disc Oculis Reports New Biomarker Data Supporting Privosegtor in Optic Neuritis Insilico Medicine and Servier Reach AI Drug Discovery Milestone Cardiff Oncology Receives FDA Orphan Drug Designation for Onvansertib Roivant Reports Positive Phase 3 Results for Brepocitinib in Uveitis Prenosis Deploys Sepsis AI Tool as ARDS Study Enrolls Sundance Biosciences Presents Positive Phase 1 Data for SUN-627 BioCryst Wins FDA Approval for ORLADEYO 150 mg Oral Pellets AstraZeneca and Oracle Partner to Advance AI in Clinical Research Sun Pharma’s UNLOXCYT Gains Preferred NCCN Status Opus Genetics Receives FDA IND Clearance for RDH12 Gene Therapy Bionyra Pharma Reports Positive Interim Phase 1 Results for BYN-002 Nanoscope Reports Durable Vision Restoration in Mice AbbVie Partners With McLaren F1 to Support Immunology Niagen Bioscience Makes Skincare a Core Tru Niagen Category Allergan Aesthetics Expands HArmonyCa Clinical Evidence Acurx Reports Microbiome-Sparing Antibiotic Research Data Novo Nordisk Reports 25% Weight Loss With CagriSema BostonGene and MUSC Partner to Advance CAR-T Therapy Insights Resolve Therapeutics Reports New Preclinical Stroke Data PHIL Report Highlights Pharma Direct-to-Patient Growth Corcept Highlights Diabetes Screening Guidance in ADA/EASD Report Lakewood-Amedex Highlights Nu-3 Antimicrobial Data Haemonetics Wins FDA Approval for PerQseal Elite Lynch Regenerative Medicine Starts Under-Eye Clinical Trial Blue Genes Lab Wins Endorsement for Genetic Drug Screening TISSIUM Receives CE Mark for ECLIPSIUM Hernia Repair System GeneDx Adds Long-Read Genome Sequencing for Rare Diseases Alcon Acquires Neurotech and FDA-Approved ENCELTO Summit and ECOG-ACRIN Launch Ivonescimab Trial in Biliary Cancer Teva and Sanofi Report Long-Term Duvakitug Data in IBD Zoetis Wins FDA Approval for Convenia RTU for Dogs Ionis Partner GSK Wins FDA Approval for Hibsago in Hepatitis B Okomera Signs First Commercial Platform Deal With Servier IBA Treats First Patient in ConformalFLASH Proton Therapy Trial Bioxodes Reports Positive Phase 2a BIOX-101 Stroke Data Alvotech Wins FDA Approval to Double SIMLANDI Batch Output Orikine Presents ORK1 Preclinical IBD Data at UEG Week 2026 Leads Biolabs Advances Opamtistomig to Phase II Expansion in Gastric Cancer Quoin Pharmaceuticals Publishes QRX003 Netherton Syndrome Case Report PolarityBio Wins SAWC Fall 2026 Award for Phase 3 SkinTE Study GSK Highlights Oncology Pipeline Ahead of ESMO 2026 Abbott Plans to Separate Its Global Nutrition Business Medicovestor Wins FDA Fast Track Designation for MC001 ADC Disc Medicine Reports Positive Phase 3 Bitopertin Results in EPP